CHRISTINA RACE: Open Payments
NPI 1003895400 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,499 in 147 payments from 19 companies in 2025. Trend: 2023 $3,503 · 2024 $1,745 · 2025 $4,499
Food & beverage: $3,059Consulting: $1,440
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $1,506 |
| Amgen Inc. | 20 | $559 |
| PFIZER INC. | 22 | $436 |
| ABBVIE INC. | 22 | $371 |
| Novartis Pharmaceuticals Corporation | 25 | $309 |
| Galderma Laboratories, L.P. | 14 | $237 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $223 |
| Regeneron Healthcare Solutions, Inc. | 4 | $186 |
| Arcutis Biotherapeutics, Inc. | 4 | $179 |
| UCB, Inc. | 4 | $94 |
Products named: OTEZLA, CIBINQO, NEMLUVIO, RINVOQ, Zoryve, SKYRIZI, Leqselvi, COSENTYX.
Industry payments across IN — which companies pay providers there.
